Company intelligence / Profile preview

Muro Pharmaceuticals

Tewksbury, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Muro Pharmaceuticals focused on respiratory and other pharmaceutical products; one asset, D-43787 for asthma, was in pending status in 2025, but the company is no longer active or independently developing products[9].

Therapeutic areas: Pulmonology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Muro Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muro Pharmaceuticals.

Explore the full profile